Bolivia Medical Device Registration: Licencia de Funcionamiento and the Annual Review

1. Key takeaways

In Bolivia, the holder of a medical device registration must be a locally incorporated enterprise that holds a valid operating licence (Licencia de Funcionamiento). Section 2.2.2 of the manual requires the submission of a certificate of the enterprise in force as evidence of that licence status, and section 5.7.2 requires every enterprise to complete an annual review before 31 December of each year. GRZAN’s assessment is that the choice of importer is the least reversible step in a Bolivian project: because the registration is tied to the licensed entity, and because the pool of qualified local partners is smaller than in neighbouring markets, due diligence has to go deeper than the size of the market would normally justify.

The reason is structural rather than commercial. A Bolivian registration is not a free-standing asset that can be moved between distributors the way a brand licence can. It is attached to a licensed establishment whose name, premises, technical responsible and tax identity appear throughout the dossier. Changing that establishment later is a regulatory project in its own right, requiring the cooperation of the very party being replaced. The quality of the initial selection therefore sets the ceiling on everything that follows, including the manufacturer’s ability to change course at all.

Two documents make the assessment concrete, and both are obtainable before signature: the ministerial resolution authorising the establishment, and the certificate of the enterprise in force for the current period. Neither is a formality. Together they establish whether the entity in front of you can lawfully be the applicant of record today, and whether it has kept that status current through the annual obligations attached to it.

2. Legal basis

The four provisions describe one continuous qualification chain. Section 2.2.1 sets the requirements that the applicant establishment must meet; section 2.2.2 converts the operating licence into a document that has to be produced on file; section 5.7.2 keeps that licence alive through an annual review fixed to a calendar date; and section 2.1 identifies who inside the enterprise may carry professional responsibility for the file. A diligence exercise that checks only the first of these will miss the two that most often lapse in practice, because a licence that was valid at signature can fall out of force before the registration is granted.

3. Expert insights

Insight 1: a small market demands heavier diligence, not lighter. The Bolivian device market is smaller than those of Peru or Colombia, and the pool of qualified local partners is correspondingly smaller. GRZAN has observed a recurring failure pattern: the manufacturer selects the only company willing to cooperate, hands over the registration, and later discovers that there is no substitute to move to. This is a structural risk rather than a contract risk, and no clause drafted afterwards can fully repair it, because the remedy requires a counterparty that the market does not offer.

Insight 2: licence validity and the enterprise certificate are two separate, checkable indicators. Diligence should obtain the current copy of the ministerial resolution granting authorisation and the certificate of the enterprise in force, then verify that the latter records completion of the annual review and the annual inspection. These two documents are the direct evidence of the importer’s compliance standing, and they answer a question that references and site visits cannot: whether the establishment is administratively current at the moment of filing, not merely whether it is competent and well regarded.

Insight 3: the technical responsible is the third diligence item. Section 2.1 of the manual lists the professions that may act as technical responsible (regente). Where the professional background of the importer’s technical responsible does not match the product category being registered, the dossier carries a latent weakness from the moment of signing onwards, because that signature attests to documentation the signatory may not be equipped to assess. This point is developed in article 33 of this series.

Insight 4: the 31 December date is a standing obligation, not a one-off event. Section 5.7.2 anchors the review to the calendar year, which means the compliance status of a partner changes on a fixed date whether or not a project is active. A registration granted in November rests on an establishment that must be reviewed again within weeks, and a manufacturer that has not tracked that date will be relying on a licence whose status it cannot confirm. Building the date into the project calendar is a low-cost control that prevents a high-cost interruption.

4. Practical recommendations

1. Request four documents at the diligence stage: the copy of the ministerial resolution granting authorisation, the certificate of the enterprise in force for the current period, the operating licence, and evidence of the professional qualification of the technical responsible.
2. Inspect the warehouse in person, and confirm that it is in a condition to accept an AGEMED inspection at any time, including storage conditions, segregation and records.
3. Assess the partner against a long-term cooperation standard rather than a single-order standard, and make substitutability part of the decision rather than an afterthought.
4. Record the 31 December review date in the project plan and confirm completion with the importer each year, keeping the confirmation on file for the duration of the registration.

5. Verification checklist

• □ The copy of the ministerial resolution granting authorisation has been obtained and checked
• □ The certificate of the enterprise is the current version and records completion of the annual review
• □ Completion of the 31 December annual review has been confirmed
• □ The professional qualification of the technical responsible covers the target product category
• □ A physical inspection of the warehouse has been completed

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers and authorised representatives with registration in Bolivia, including diligence on locally licensed holders under sections 2.2.1, 2.2.2 and 5.7.2 of Resolución Ministerial N° 010, the verification of operating licences and enterprise certificates, and the structuring of importer relationships that remain workable over the life of a registration. For assistance with partner selection or dossier planning in Bolivia, contact the GRZAN regulatory team at info@grzanglobal.com.

GRZAN applies a writing standard of conclusions first, traceable sources and verifiable figures to all of its regulatory publications, and tracks the practice of AGEMED and the other authorities cited in this series as it develops. For a market access plan built around a specific product and a specific local partner in Bolivia, the team welcomes your enquiry.